Evidence map›Paper›PMID 42002421›Full record

ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2026

Corrigendum to "Characterization of focused ultrasound blood-brain barrier disruption effect on inflammation as a function of treatment parameters" [Biomed. Pharmacother. 182 (2025) 117762].

Cleide Angolano, Emily Hansen, Hala Ajjawi, Paige Nowlin, Yongzhi Zhang, Natale Fomin-Thunemann, Christiane Ferran, Nick Todd

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Cleide AngolanoDivision of Vascular and Endovascular Surgery, Center for Vascular Biology Research, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Emily HansenHarvard University, Cambridge, MA, United States.
Hala AjjawiHarvard University, Cambridge, MA, United States.
Paige NowlinDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Yongzhi ZhangDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Natale Fomin-ThunemannDepartment of Biomedical Engineering, Boston University, Boston, MA, United States.
Christiane FerranDivision of Vascular and Endovascular Surgery, Center for Vascular Biology Research, Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States; Division of Nephrology and the Transplant Institute, Department of Nephrology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
Nick ToddDepartment of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States. Electronic address: ntodd1@bwh.harvard.edu.

Funding

Improved Delivery of Gene Therapies to the Central Nervous System by Focused Ultrasound-Mediated Disruption of the Blood-Brain BarrierR01NS123557 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI Nicholas E. Todd · 2022 to 2026
$2.3M
Understanding the relationships between FUS-BBB opening, neuroinflammation and the neurovascular responseR21EB030173 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI TODD, NICHOLAS E. · 2020 to 2022
$739k
NIBIB NIH HHS R21 EB030173NINDS NIH HHS R01 NS123557
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42002421
PMCPMC13366418

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.